Anticancer Drug Utilization and Prescription Practices at a Saudi Cancer Center: A Retrospective Study (2014–2022)

We conducted a retrospective cohort study of 510 adult patients with histologically confirmed malignant neoplasms that were managed with anti-cancer therapy at King Khaled Hospital, Najran, from 2014 to 2022. Data extraction included demographic characteristics, treatment regimens, and supportive medications, analyzed using IBM SPSS Statistics (version 21). Prescription quality was assessed against WHO EML criteria and Saudi Food and Drug Authority (SFDA) standards.